Dosing Information for SARCLISA

Treatment is repeated until disease progression or unacceptable toxicity.

Premedication should be administered 15 to 60 minutes
prior to infusion of SARCLISA

Incremental escalation of the infusion rate should be considered only in the absence of IRRs.

Calculated infusion times

Weekly dosing transitions to every other week after the first cycle

Treatment is administered in 28-day cycles.

Expert review Join Joseph Mikhael, MD, and Kenneth Shain, MD, PhD, as they examine the dosing and administration for SARCLISA

IRR=infusion-related reaction; IV=intravenous; Pd=pomalidomide and dexamethasone.